Results 11 to 20 of about 1,883,437 (383)

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

open access: yesNature, 2021
The SARS-CoV-2 B.1.1.529 (Omicron) variant contains 15 mutations of the receptor-binding domain (RBD). How Omicron evades RBD-targeted neutralizing antibodies requires immediate investigation.
Yunlong Cao   +29 more
semanticscholar   +1 more source

Antiviral neutralizing antibodies: from in vitro to in vivo activity

open access: yesNature reviews. Immunology, 2023
Neutralizing antibodies (nAbs) are being increasingly used as passive antiviral reagents in prophylactic and therapeutic modalities and to guide viral vaccine design.
D. Burton
semanticscholar   +1 more source

Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination

open access: yesNature Medicine, 2022
The recent emergence of the SARS-CoV-2 Omicron variant is raising concerns because of its increased transmissibility and its numerous spike mutations, which have the potential to evade neutralizing antibodies elicited by COVID-19 vaccines.
E. Pérez-Then   +25 more
semanticscholar   +1 more source

Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model

open access: yesScience, 2020
Protective neutralizing antibodies Antibodies produced by survivors of coronavirus disease 2019 (COVID-19) may be leveraged to develop therapies. A first step is identifying neutralizing antibodies, which confer strong protection against severe acute ...
T. Rogers   +33 more
semanticscholar   +1 more source

Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses

open access: yesNature reviews. Immunology, 2022
The ancestral strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved into a number of variants of concern. In this Review, Wang and colleagues discuss progress in the development and characterization of broadly neutralizing ...
Yanjia Chen   +5 more
semanticscholar   +1 more source

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies

open access: yesNature reviews. Immunology, 2022
After nearly four decades of research, a safe and effective HIV-1 vaccine remains elusive. There are many reasons why the development of a potent and durable HIV-1 vaccine is challenging, including the extraordinary genetic diversity of HIV-1 and its ...
B. Haynes   +10 more
semanticscholar   +1 more source

HIV-1 Env Does Not Enable the Development of Protective Broadly Neutralizing Antibodies in an Experimental Autoimmune Encephalomyelitis Mouse Model

open access: yesFrontiers in Immunology, 2021
Recent studies showed that immunological tolerance may restrict the development of Env-specific autoreactive broadly neutralizing antibodies. This evidence is consistent with the finding that Env immunization of a systemic lupus erythematosus (SLE ...
Gabriel Siracusano   +5 more
doaj   +1 more source

Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals

open access: yesNature Medicine, 2022
In July 2022, the ongoing monkeypox (MPX) outbreak was declared a public health emergency of international concern. Modified vaccinia Ankara—Bavarian Nordic (MVA-BN, also known as Imvamune, JYNNEOS or Imvanex) is a third-generation smallpox vaccine that ...
Luca M. Zaeck   +18 more
semanticscholar   +1 more source

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

open access: yesScience, 2020
Sites of vulnerability in SARS-CoV-2 Antibodies that neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could be an important tool in treating coronavirus disease 2019 (COVID-19). Brouwer et al.
P. Brouwer   +32 more
semanticscholar   +1 more source

Broadly neutralizing antibodies target the coronavirus fusion peptide

open access: yesbioRxiv, 2022
The potential for future coronavirus outbreaks highlights the need to develop strategies and tools to broadly target this group of pathogens. Here, using an epitope-agnostic approach, we identified six monoclonal antibodies that bound to spike proteins ...
Cherrelle Dacon   +41 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy